Please assess the completion status of the following clinical trial:

Trial Title: A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is male/female and 6 to 17 years of age at the time of study with hypertension (high blood pressure)~* Patient is able to swallow tablets~* Females of child bearing potential must use acceptable contraception throughout the trial~Exclusion Criteria:~* Patient has a history of heart, metabolic or kidney disease~* Patient has a history of known heart, lung, liver and other body system disorders~* Patient is pregnant or nursing~* Patient has participated in another clinical trial within the last 28 days

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Losartan 50 mg (Type: ACTIVE_COMPARATOR): Losartan 50 mg tablet, oral, once daily for 4 weeks. Participant also will be co-administered placebo for losartan 50 mg/hydrochlorothiazide (HCTZ) 12.5 mg once daily for 4 weeks
- Losartan 100 mg (Type: ACTIVE_COMPARATOR): Losartan 100 mg tablet, oral, once daily for 4 weeks. Participant also will be co-administered placebo for losartan 100 mg/hydrochlorothiazide (HCTZ) 12.5 mg once daily for 4 weeks
- Losartan 50 mg/HCTZ 12.5 mg (Type: EXPERIMENTAL): Losartan 50 mg/hydrochlorothiazide (HCTZ) 12.5 mg tablet, oral, once daily for 4 weeks. Participant also will be co-administered placebo for losartan 50 mg once daily for 4 weeks
- Losartan 100 mg/HCTZ 12.5 mg (Type: EXPERIMENTAL): Losartan 100 mg/hydrochlorothiazide (HCTZ) 12.5 mg tablet, oral, once daily for 4 weeks. Participant also will be co-administered placebo for losartan 100 mg once daily for 4 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).